Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

NCT00003471 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Low-Grade Astrocytoma, Nos

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute